Skip to main content
Clinical Trials/NCT02320760
NCT02320760
Completed
Not Applicable

Physical Activity in Prevention and Treatment of Overweight, Central Obesity and the Metabolic Syndrome - a Randomised Controlled Study in Overweight 65 Year Old Women and Men

Karolinska Institutet0 sites102 target enrollmentJanuary 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Physical Activity Level
Sponsor
Karolinska Institutet
Enrollment
102
Primary Endpoint
physical activity level
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This randomized controlled study evaluates the effect of individualized physical activity on prescription (PAP) in older overweight adults. The primary hypothesis is that an individualized prescription of physical activity increases physical activity level in overweight older adults after 6 months. Secondary hypothesis are that the increased physical activity level will improve cardio metabolic risk factors and quality of life.

200 women and men, aged 65 with low physical activity level, overweight, and abdominal obesity, will be randomized to an intervention group or a control group. The control group receives general information about physical activity and registration of physical activity level for one week. The intervention group receives in addition an individualized physical activity on prescription with patient-centered counseling.

After six months both groups go through the same health check-up as at baseline and follow-ups take place after 12 and 24 months.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
May 2009
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mai-Lis Hellénius, Professor

Proffesor

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • BMI between 25 and 40
  • waist circumference over 88 cm for women and 102 cm for men
  • basically healthy
  • mostly sedentary in their leisure time

Exclusion Criteria

  • current heart disease
  • tablet or insulin treated diabetes type 2
  • other chronic serious illness

Outcomes

Primary Outcomes

physical activity level

Time Frame: 6 months

Secondary Outcomes

  • cardiometabolic risk factors(6 months)

Similar Trials